Long-term safety and effectiveness of vonoprazan as maintenance therapy for reflux esophagitis in Japan: a 12-month post-marketing surveillance study

Key Points

• To evaluate the long-term safety and effectiveness of vonoprazan as a maintenance therapy for reflux esophagitis.
• Conducted a 12-month post-marketing surveillance study in Japan.
• Monitored patients receiving maintenance therapy with vonoprazan.
• Assessed the incidence of adverse drug reactions (ADRs) and RE recurrence.
• Vonoprazan effectively prevented recurrence of reflux esophagitis during maintenance therapy.
• The incidence of adverse drug reactions was low and no new safety signals were identified.